Merck Balance Sheet Health
Financial Health criteria checks 4/6
Merck has a total shareholder equity of $43.6B and total debt of $37.8B, which brings its debt-to-equity ratio to 86.6%. Its total assets and total liabilities are $112.6B and $69.0B respectively. Merck's EBIT is $19.8B making its interest coverage ratio 20.7. It has cash and short-term investments of $11.4B.
Key information
86.6%
Debt to equity ratio
US$37.79b
Debt
| Interest coverage ratio | 20.7x |
| Cash | US$11.35b |
| Equity | US$43.65b |
| Total liabilities | US$68.98b |
| Total assets | US$112.63b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: MRK's short term assets ($38.2B) exceed its short term liabilities ($26.1B).
Long Term Liabilities: MRK's short term assets ($38.2B) do not cover its long term liabilities ($42.9B).
Debt to Equity History and Analysis
Debt Level: MRK's net debt to equity ratio (60.6%) is considered high.
Reducing Debt: MRK's debt to equity ratio has reduced from 95.9% to 86.6% over the past 5 years.
Debt Coverage: MRK's debt is well covered by operating cash flow (44.2%).
Interest Coverage: MRK's interest payments on its debt are well covered by EBIT (20.7x coverage).